1. Home
  2. EBTC vs SAGE Comparison

EBTC vs SAGE Comparison

Compare EBTC & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBTC
  • SAGE
  • Stock Information
  • Founded
  • EBTC 1989
  • SAGE 2010
  • Country
  • EBTC United States
  • SAGE United States
  • Employees
  • EBTC N/A
  • SAGE N/A
  • Industry
  • EBTC Major Banks
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • EBTC Finance
  • SAGE Health Care
  • Exchange
  • EBTC Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • EBTC 446.9M
  • SAGE 415.0M
  • IPO Year
  • EBTC 2005
  • SAGE 2014
  • Fundamental
  • Price
  • EBTC $38.98
  • SAGE $6.71
  • Analyst Decision
  • EBTC
  • SAGE Hold
  • Analyst Count
  • EBTC 0
  • SAGE 19
  • Target Price
  • EBTC N/A
  • SAGE $9.88
  • AVG Volume (30 Days)
  • EBTC 21.2K
  • SAGE 934.8K
  • Earning Date
  • EBTC 04-17-2025
  • SAGE 04-29-2025
  • Dividend Yield
  • EBTC 2.59%
  • SAGE N/A
  • EPS Growth
  • EBTC 11.95
  • SAGE N/A
  • EPS
  • EBTC 3.27
  • SAGE N/A
  • Revenue
  • EBTC $172,242,000.00
  • SAGE $47,404,000.00
  • Revenue This Year
  • EBTC N/A
  • SAGE $100.64
  • Revenue Next Year
  • EBTC N/A
  • SAGE $70.19
  • P/E Ratio
  • EBTC $11.73
  • SAGE N/A
  • Revenue Growth
  • EBTC 7.98
  • SAGE N/A
  • 52 Week Low
  • EBTC $22.60
  • SAGE $4.62
  • 52 Week High
  • EBTC $44.41
  • SAGE $14.56
  • Technical
  • Relative Strength Index (RSI)
  • EBTC 60.92
  • SAGE 35.06
  • Support Level
  • EBTC $38.23
  • SAGE $7.23
  • Resistance Level
  • EBTC $39.41
  • SAGE $7.63
  • Average True Range (ATR)
  • EBTC 0.96
  • SAGE 0.29
  • MACD
  • EBTC 0.45
  • SAGE -0.09
  • Stochastic Oscillator
  • EBTC 91.98
  • SAGE 0.38

About EBTC Enterprise Bancorp Inc

Enterprise Bancorp Inc is a holding company engaged in the business of gathering deposits from the general public and investing in loans and investment securities. Through the Bank and its subsidiaries, the company offers a range of commercial, residential, and consumer loan products, deposit products, and cash management services, as well as wealth management and wealth services.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: